Identification of patient population with longer survival when treated with S-1 plus cisplatin via predictive enrichment strategy analysis of the FLAGS phase III trial.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jaffer A. Ajani, Madoka Takeuchi, Masahiro Takeuchi
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891225200
